After-hours movers: Broadcom, lululemon, Rocket Lab and more

Rubrik Inc (RBRK) PT Raised to $117 at Goldman Sachs

Goldman Sachs analyst Kash Rangan raised the price target on Rubrik Inc (NYSE: RBRK) to $117.00 (from $82.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy rating and raise our PT to $117 ($82 prior) after impressive F1Q results that saw Revenue +7% vs. Consensus, Subscription ARR +2% (with Cloud ARR +60% vs. +67% in F4Q25), and Contribution Margin of 8% (+300bps vs. GSe). The stock is flat AH as,... More

Broadcom Limited (AVGO) PT Raised to $295 at Truist Securities, 'Buy the near-term weakness'

Truist Securities analyst William Stein raised the price target on Broadcom Limited (NASDAQ: AVGO) to $295.00 (from $267.00) while maintaining a Buy rating.

The analyst comments "Buy the near-term weakness. AVGO posted very modest upside to CQ1 (Apr) results, and CQ2 (July) guidance.... More

William Blair on Braze Inc (BRZE) with Shares Down 10pct Post Earnings: 'buyers on the pullback'

William Blair analyst Arjun Bhatia reiterated an Outperform rating on Braze Inc (NASDAQ: BRZE).

The analyst comments "Braze continues to deliver strong results despite what is a somewhat noisy environment. In our view, Braze continues to be a key beneficiary of the increasing use of first-party data to engage customers and drive... More

Lululemon Athletica Inc. (LULU) PT Lowered to $290 at UBS

UBS analyst Jay Sole lowered the price target on Lululemon Athletica Inc. (NASDAQ: LULU) to $290.00 (from $330.00) while maintaining a Neutral rating.

The analyst comments "Top 5 most notable datapoints from LULU's 1Q25 report: 1) LULU mgmt. noted US total sales 2QTD is... More

Braze Inc (BRZE) PT Lowered to $44 at Oppenheimer

Oppenheimer analyst Brian Schwartz lowered the price target on Braze Inc (NASDAQ: BRZE) to $44.00 (from $51.00) while maintaining a Outperform rating.

The analyst comments "Braze's F1Q results were above consensus estimates, though the magnitude and quality of the revenue beat was low.... More

Broadcom Limited (AVGO) PT Raised to $315 at Benchmark

Benchmark analyst Cody Acree raised the price target on Broadcom Limited (NASDAQ: AVGO) to $315.00 (from $255.00) while maintaining a Buy rating.

Lululemon Athletica Inc. (LULU) PT Lowered to $370 at BofA Securities

BofA Securities analyst Lorraine Hutchinson lowered the price target on Lululemon Athletica Inc. (NASDAQ: LULU) to $370.00 (from $400.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy rating; sales plans are on track, and we are encouraged by successful... More

Lululemon Athletica Inc. (LULU) PT Lowered to $324 at Stifel

Stifel analyst Jim Duffy lowered the price target on Lululemon Athletica Inc. (NASDAQ: LULU) to $324.00 (from $353.00) while maintaining a Buy rating.

The analyst comments "The multi-year growth thesis is intact despite a slow start to 2025 internationally. Revenue of $2,371mn and $2.60 EPS beat Stifels $2,364mn/$2.59... More

Broadcom Limited (AVGO) PT Raised to $325 at JPMorgan

JPMorgan analyst Harlan Sur raised the price target on Broadcom Limited (NASDAQ: AVGO) to $325.00 (from $250.00) while maintaining a Overweight rating.

The analyst comments "We see the recent ruling from the U.S. District Court for the District of Delaware in favor of ACAD regarding its 721 formulation patent for Nuplazid (pimavanserin) on both infringement and validity arguments against Aurobindo Pharma and other ANDA filers (see document here) as a clear positive. Note that the 721 patent provides protection for the Nuplazid 34mg capsule formulation into 2038. We believe it is logical to assume the parties... More

Lululemon Athletica Inc. (LULU) PT Lowered to $270 at Citi

Citi analyst Paul Lejuez lowered the price target on Lululemon Athletica Inc. (NASDAQ: LULU) to $270.00 (from $325.00) while maintaining a Neutral rating.

The analyst comments "

1Q was disappointing. Total comps +1% were below cons +4% driven by weaker China (+8% vs cons +18%)/ROW comps (+7% vs cons... More

Broadcom Limited (AVGO) PT Raised to $270 at Morgan Stanley

Morgan Stanley analyst Joseph Moore raised the price target on Broadcom Limited (NASDAQ: AVGO) to $270.00 (from $260.00) while maintaining a Overweight rating.

The analyst comments "Thoughts on the stock: AVGO seems the most uncontroversial of the AI names ever since the 2027 SAM raised longer term expectations. That makes sense... More

Broadcom Limited (AVGO) PT Raised to $304 at Evercore ISI, 'We’re Still Buyers'

Evercore ISI analyst Mark Lipacis raised the price target on Broadcom Limited (NASDAQ: AVGO) to $304.00 (from $267.00) while maintaining a Outperform rating.

The analyst comments "Were Still Buyers of AVGO after an in-line AprQ print and implied EPS outlook that is $0.01 below consensus. AI revs... More

Broadcom Limited (AVGO) PT Raised to $315 at KeyBanc

KeyBanc analyst John Vinh raised the price target on Broadcom Limited (NASDAQ: AVGO) to $315.00 (from $275.00) while maintaining a Overweight rating.

The analyst comments "AVGO reported solid F2Q (Apr) results and provided mixed F3Q (Jul) guidance (higher revs, lower... More